Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 10 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
LENANS from Mons, company number BE0433113116, closed financial year 2025 with a result of € 11,450 after tax. For that financial year LENANS recorded a gross margin of € 56,393 and equity of € 719,922. Compared with financial year 2024, the result moved from € 68,942 to € 11,450. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 31, 2026.
€ 719,922
▲ 2% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 11,450
▼ 83% vs 2024
Profit after tax over the fiscal year.
€ 2,294
▼ 57% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 657,922.
Debts at end 2025
€ 467,662
▼ 6% vs 2024
€ 58,758 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.
€ 89,562
▲ 41% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 6,942
▼ 67% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 97,414 | € 118,730 | € 125,701 | € 56,393 | ▼ 55% |
| Profit after taxes | € 46,084 | € 64,164 | € 68,942 | € 11,450 | ▼ 83% |
| Equity | € 645,365 | € 669,529 | € 708,471 | € 719,922 | ▲ 2% |
| Total debts | € 940,689 | € 887,630 | € 731,846 | € 724,609 | ▼ 1% |
| Cash | € 34,149 | € 88,084 | € 5,331 | € 2,294 | ▼ 57% |
| Land & buildings | € 581,753 | € 555,811 | € 529,869 | € 503,927 | ▼ 5% |
| Retained profit | € 583,365 | € 607,529 | € 646,471 | € 657,922 | ▲ 2% |
| Dividend | € 20,000 | € 40,000 | € 30,000 | € 0 | ▼ 100% |
| Bank debt | € 655,893 | € 561,000 | € 498,673 | € 467,662 | ▼ 6% |
| Balance sheet total | € 1,735,961 | € 1,699,334 | € 1,574,760 | € 1,571,150 |
By gross margin, LENANS ranks 399th of 478 companies with main activity “Detailhandel in farmaceutische producten” in Hainaut that publish figures (fiscal year 2025).
Key figures of LENANS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about LENANS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to LENANS?
What happened at LENANS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- BLUESTONE SRL stepped down as director. NBB
- SERGE RANSART stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 11,450 (▼ 83% vs 2024). Source: NBB ↗
- BLUESTONE SRL became a director. NBB
- SERGE RANSART became a director. NBB
- New establishment in Mons. KBO
- Start of the company according to the CBE. KBO
In short
From € 46,084 profit in 2022 to € 11,450 profit in 2025.
Paid € 56,782 in corporate taxes since 2022.
Best year ever: 2024, with € 68,942 profit.
Paid out € 90,000 in dividends to the owners in total.
Management
The stake of Société de Participations et de Gestion Financières et Immobilières, BLUESTONE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
LENANSThe shares are held by Société de Participations et de Gestion Financières et Immobilières (50%) and BLUESTONE (50%). It owns 40% of PHARMALLIANCE itself.
Directors
According to the 2025 annual accounts
Managing director · represented by RANSART PAUL
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, PHARMACIE de BARRY, PALATINE, IMMOLENANS, ANCIAUX, TORNAPHAR, DIGITALE, DELTAPHAR +7 more
since 2016 · until 2028
SERGE RANSART
Director
Also active at: COMPAGNIE FINANCIERE ET IMMOBILIERE DE LA DYLE, ANCIAUX, LES PHARMACIES RURALES, TORNAPHAR, COMPAGNIE FONCIERE ET FINANCIERE, CAPITOLIUM, ANTARES INVEST
since 2016 · until 2028
Shareholders
Participations
40%
Establishments
Establishment units
Physical locations of this company
Chaussée du Roi Baudouin 192 box A
7030 Mons
Chaussée de Binche 188
7000 Mons
Active since 4 March 1988
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Hainaut
Same main activity (Detailhandel in farmaceutische producten), 514 active companies in Hainaut, largest first.
€ 51.5 million revenue · 2025 · Frameries
€ 3.9 million gross margin · 2025 · Enghien
LES PHARMACIES BENIT-DEHAUT-RION
€ 1.9 million gross margin · 2025 · Dour
€ 1.9 million gross margin · 2025 · Antoing
€ 1.5 million gross margin · 2025 · Celles (lez-Tournai)
€ 1.4 million gross margin · 2025 · Silly
Details
- Company number
- 0433.113.116
- VAT number
- BE 0433.113.116
- Registered office
- Chaussée du Roi Baudouin 192 bus A, 7030 Mons
- Names & denominations
- LENANS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 January 1988
- Peppol
- Active · Active since 24 Nov 2023
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers